Verve Therapeutics Inc VERV Valuation Ratios and Share Stats

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Verve Therapeutics Inc (VERV)
Verve Therapeutics Inc (VERV) Financials

Verve Therapeutics Inc (VERV)

8.50

-0.08

( -0.93% )

Updated: 15:51:12

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-178.288	-91.353	-52.024	-29.602	-27.944
Return on Equity (%)	197.381	109.521	-82.002	-34.656	-34.781
Return on Invested Capital (%)	-479.339	-122.223	-42.45	-37.039	-39.259
Operating Margin (%)	N/A	N/A	N/A	-8105.822	-1699.209
Net Profit Margin (%)	N/A	N/A	N/A	-8108.552	-1701.548
Book Value Per Share	3.197	23.686	7.366	8.925	9.404
Earnings Per Share	-10.408	-17.674	-2.48	-2.55	-3.138
Cash Per Share	1.611	3.478	1.326	1.87	3.234
Working Capital Per Share	8.361	25.774	7.114	8.554	9.426
Operating Profit Per Share	N/A	N/A	N/A	0.031	0.184
EBIT Per Share	-10.408	-17.674	-2.48	-2.549	-3.134
EBITDA Per Share	-10.408	-17.674	-2.48	-2.549	-3.134
Free Cash Flow Per Share	-9.464	-16.863	-2.422	-2.381	-3.078

Liquidity Ratios

Year End December 30 2023	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	1.85M	2.59M	48.51M	61.73M	N/A

Key Stats and Ratios

Year End December 30 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	60.44M	61.73M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-3701.923	N/A	N/A	N/A	-853.907	N/A
Net Profit Margin (%)	N/A	N/A	-3701.923	N/A	N/A	N/A	-855.768	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	726.42M
Price to Earnings Ratio	-3.53
Price to Sales Ratio	60.12
Price to Cash Ratio	3.43
Price to Book Ratio	1.18
Dividend Yield	-

Share Statistics

Shares Outstanding	84.66M
Average Volume (1 week)	1.02M
Average Volume (1 Month)	1.6M
52 Week Change	-33.95%
52 Week High	19.34
52 Week Low	4.305

More Ratios Coming Soon!

Verve Therapeutics

Enbridge Inc 550 (PK)

BNP Paribas Issuance

Delayed Upgrade Clock